These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10027857)
1. [3H]gemcitabine uptake by nucleoside transporters in a human head and neck squamous carcinoma cell line. Hammond JR; Lee S; Ferguson PJ J Pharmacol Exp Ther; 1999 Mar; 288(3):1185-91. PubMed ID: 10027857 [TBL] [Abstract][Full Text] [Related]
2. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells. Burke T; Lee S; Ferguson PJ; Hammond JR J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397 [TBL] [Abstract][Full Text] [Related]
3. 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells. Cory JG; Downes DL; Ng CY; Belt JA Oncol Res; 1992; 4(4-5):175-9. PubMed ID: 1504377 [TBL] [Abstract][Full Text] [Related]
4. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells. Borgland SL; Parkinson FE J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516 [TBL] [Abstract][Full Text] [Related]
5. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. Mackey JR; Yao SY; Smith KM; Karpinski E; Baldwin SA; Cass CE; Young JD J Natl Cancer Inst; 1999 Nov; 91(21):1876-81. PubMed ID: 10547395 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758 [TBL] [Abstract][Full Text] [Related]
7. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Mackey JR; Mani RS; Selner M; Mowles D; Young JD; Belt JA; Crawford CR; Cass CE Cancer Res; 1998 Oct; 58(19):4349-57. PubMed ID: 9766663 [TBL] [Abstract][Full Text] [Related]
8. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells. Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472 [TBL] [Abstract][Full Text] [Related]
9. L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities. Vijayalakshmi D; Dagnino L; Belt JA; Gati WP; Cass CE; Paterson AR J Biol Chem; 1992 Aug; 267(24):16951-6. PubMed ID: 1512237 [TBL] [Abstract][Full Text] [Related]
10. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Hammond JR Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851 [TBL] [Abstract][Full Text] [Related]
11. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells. Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747 [TBL] [Abstract][Full Text] [Related]
12. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes. Lostao MP; Mata JF; Larrayoz IM; Inzillo SM; Casado FJ; Pastor-Anglada M FEBS Lett; 2000 Sep; 481(2):137-40. PubMed ID: 10996312 [TBL] [Abstract][Full Text] [Related]
13. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2. Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416 [TBL] [Abstract][Full Text] [Related]
14. Differential uptake of [3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells. Hammond JR Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):431-6. PubMed ID: 1445201 [TBL] [Abstract][Full Text] [Related]
15. Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity. Damaraju VL; Scriver T; Mowles D; Kuzma M; Ryan AJ; Cass CE; Sawyer MB Clin Cancer Res; 2014 Jan; 20(1):176-86. PubMed ID: 24170548 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells. Hammond JR J Pharmacol Exp Ther; 1991 Nov; 259(2):799-807. PubMed ID: 1941627 [TBL] [Abstract][Full Text] [Related]
17. Nucleoside transport in brush border membrane vesicles from human kidney. Gutierrez MM; Brett CM; Ott RJ; Hui AC; Giacomini KM Biochim Biophys Acta; 1992 Mar; 1105(1):1-9. PubMed ID: 1567888 [TBL] [Abstract][Full Text] [Related]
18. Characterization of equilibrative and concentrative Na+-dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells. Roovers KI; Meckling-Gill KA J Cell Physiol; 1996 Mar; 166(3):593-600. PubMed ID: 8600163 [TBL] [Abstract][Full Text] [Related]